Secukinumab provides rapid and persistent relief in pain and fatigue symptoms in patients with ankylosing spondylitis irrespective of baseline C-reactive protein levels or prior tumour necrosis factor inhibitor therapy: 2-year data from the MEASURE
| Image |  |
|---|---|
| Description | scientific article published on 19 July 2018 |
| Author/s |
author: Vibeke Strand Brian Porter Tore K. Kvien |
| Publication date | July 19, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |